ELETRIPTAN f.c. tablets

ELETRIPTAN f.c. tablets
Product Description

Strength: 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Migraine Treatment Innovator: Relpax (Pfizer)

Rafarm S.A

  • GR
  • 2015
    On CPHI since

Rafarm S.A

  • GR
  • 2015
    On CPHI since

More Products from Rafarm S.A (38)

  • DEXAMETHASONE soluble tablets

    Product DEXAMETHASONE soluble tablets

    Strength:  0.5 mg/tab; 2 mg/tab; 4 mg/tab; 8 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Glucocorticoid Therapy Innovator: - (-)
  • DONEPEZIL f.c. tablets

    Product DONEPEZIL f.c. tablets

    Strength: 5 mg/tab; 10 mg/tab Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
  • DONEPEZIL oral solution

    Product DONEPEZIL oral solution

    Strength: 1 mg/ml Presentation: bottles, 150 ml Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
  • DORZOLAMIDE + TIMOLOL eye drops solution

    Product DORZOLAMIDE + TIMOLOL eye drops solution

    Strength: (20 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Cosopt (Merk & Co)
  • DORZOLAMIDE eye drops solution

    Product DORZOLAMIDE eye drops solution

    Strength: 20 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Trusopt (Merk & Co)
  • DUTASTERIDE soft gel capsules

    Product DUTASTERIDE soft gel capsules

    Strength: 0.5 mg/cap Therapeutic area: Benign Prostatic Hyperplasia Innovator: Avodart (GSK)
  • EZETIMIBE tablets

    Product EZETIMIBE tablets

    Strength: 10 mg/tab Therapeutic area: Primary Hypercholesterolaemia, Homozygous Familial Hypercholesterolaemia, Homozygous Sitosterolaemia Innovator: Ezetrol (Merck & Co)
  • FERROUS GLUCONATE effervescent granules

    Product FERROUS GLUCONATE effervescent granules

    Strength: 695 mg (80 mg/Fe++)/sachet Presentation: single dose sachet Therapeutic area: Iron Deficiency Innovator: Viofer (Viofar)
  • ILOPROST concentrate solution for infusion

    Product ILOPROST concentrate solution for infusion

    Strength: 20 mcg/ml; 100 mcg/ml Presentation: ampoules, 0.5 ml (100 mcg/ml); 1 ml (20 mcg/ml & 100 mcg/ml); 2.5 ml (20 mcg/ml) Therapeutic area: Severe peripheral arterial occlusive disease (PAOD) Innovator: Ilomedin (Bayer)
  • ILOPROST nebulizer solution

    Product ILOPROST nebulizer solution

    Strength: 10 mcg/ml; 20 mcg/ml Presentation: ampoules, 1 ml & 2 ml Therapeutic area: Pulmonary hypertension Innovator: Ventavis (Bayer)
  • IRON SUCROSE COMPLEX solution for injection/concentrate solution for infusion

    Product IRON SUCROSE COMPLEX solution for injection/concentrate solution for infusion

    Strength: 20 mg Iron/ml Presentation: ampoules, 5 ml & vials, 5 ml Therapeutic area: Iron Deficiency Innovator: Venofer (Vifor)
  • LATANOPROST + TIMOLOL eye drops solution

    Product LATANOPROST + TIMOLOL eye drops solution

    Strength: (50 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalacom (Pfizer)